Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies

European Journal of Medicinal Chemistry

Volumn 43, Issue 8, 2008, Pages 1791-1795

  Cheng, Yiyun ^a,b   Li, Mingzhong ^a   Xu, Tongwen ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Anti cancer drugs; Camptothecin; Drug carrier; PAMAM; Poly(amidoamine) dendrimers; Solubility

Indexed keywords

CAMPTOTHECIN; DENDRIMER; DRUG CARRIER; POLYAMIDOAMINE;

AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; DRUG SOLUBILITY; ENCAPSULATION;

CAMPTOTHECIN; CAPSULES; DENDRIMERS; DRUG CARRIERS; MOLECULAR STRUCTURE; POLYAMINES; SOLUBILITY;

EID: 47949125776     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.09.030     Document Type: Article

References (41)

1. Opanasopit P., Ngawhirunpat T., Chaidedgumjorn A., Rojanarata T., Apirakaramwong A., Phongying S., Choochottiros C., and Chirachanchai S. Incorporation of camptothecin into n-phthaloyl ChitoSAN-g-mPEG self-assembly micellar system. European Journal of Pharmaceutics and Biopharmaceutics 64 (2006) 269-276
2. Berrada M., Serreqi A., Dabbarh F., Owusu A., Gupta A., and Lehnert S. A novel non-toxic camptothecin formulation for cancer chemotherapy. Biomaterials 26 (2005) 2115-2120
3. Zhu A.P., Liu J.S., and Ye W.H. Effective loading and controlled release of camptothecin by O-carboxymethylchitosan aggregates. Carbohydrate Polymers 63 (2006) 89-96
4. Kumi K., Masato W., Tatsuhiro Y., Masayuki Y., Praneet O., Teruo O., and Yoshie M. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. Journal of Controlled Release 112 (2006) 329-332
5. Watanabe M., Kawano K., Yokoyama M., Opanasopit P., Okano T., and Maitani Y. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. International Journal of Pharmaceutics 308 (2006) 183-189
6. Tomalia D.A., Baker H., and Dewald J. A new class of polymers: starburst-dendritic macromolecules. Polymer Journal 17 (1985) 117
7. Tomalia D.A., Baker H., and Dewald J.R. Dendritic molecules: synthesis of starburst dendrimer. Macromolecules 19 (1986) 2466
8. D.A. Tomalia, J.R. Dewald, Dense Star Polymers Having Two Dimensional Molecular Diameter, U.S. Patent 4,587,329 (1986).
9. Tomalia D.A., Naylor A.M., and Goddard W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angewandte Chemie International Edition in English 29 (1990) 138
10. Furuta P., and Fréchet J.M.J. Controlling solubility and modulating peripheral function in dendrimer encapsulated dyes. Journal of the American Chemical Society 125 (2003) 13173-13181
11. Svenson S., and Tomalia D.A. Dendrimers in biomedical applications-reflections on the field. Advanced Drug Delivery Reviews 57 (2005) 2106-2129
12. Roseita E., and Tomalia D.A. Poly (amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Delivery Today 6 (2001) 427-436
13. Anil K.P., Majoros I.J., and Baker J.R. Dendritic polymer macromolecular carriers for drug delivery. Current Opinion in Chemical Biology 6 (2002) 466-471
14. Elizabeth R.G., and Fréchet J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Delivery Today 10 (2005) 35-43
15. Milhem O.M., Myles C., and McKeown N.B. Polyamidoamine starburst dendrimers as solubility enhancers. International Journal of Pharmaceutics 197 (2000) 239-241
16. Kolhe P., Misra E., Kannan R.M., Kannan S., and Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. International Journal of Pharmaceutics 259 (2003) 143-160
17. Kannan S., Kolhe P., Raykova V., Glibatec M., Kannan R.M., Lieh-Lai M., and Bassett D. Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. Journal of Biomaterials Science, Polymer Edition 15 (2004) 311-330
18. Cheng Y.Y., and Xu T.W. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. European Journal of Medicinal Chemistry 40 (2005) 1188-1192
19. Ma M.L., Cheng Y.Y., Xu Z.H., Xu P., Qu H.O., Fang Y.J., Xu T.W., and Wen L.P. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. European Journal of Medicinal Chemistry 42 (2007) 93-98
20. Cheng Y.Y., Qu H.O., Ma M.L., Xu Z.H., Xu P., Fang Y.J., Xu T.W., and Wen L.P. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study. European Journal of Medicinal Chemistry 42 (2007) 1032-1038
21. Malik N., Evagorou E.G., and Duncan R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anti-Cancer Drugs 10 (1999) 767-776
22. Zhuo R.X., Du B., and Lu Z.R. In vitro release of 5-fluorouracil with cyclic core dendritic polymer. Journal of Controlled Release 57 (1999) 249-257
23. Kojima C., Kono K., Maruyama K., and Takagishi T. Synthesis of polyamidoamine dendrimers having poly (ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugation Chemistry 11 (2000) 910-917
24. Cheng Y.Y., and Yang J.P. Solubilization of non-steroidal anti-inflammatory drugs in the presence of tween series surfactants. Physics and Chemistry of Liquids 44 (2006) 249-256
25. Kang J.C., Kumar V., Yang D., Chowdhury P.R., and Hohl R.J. Cyclodextrin complexation: influence on the solubility, stability and cytotoxicity of camptothecin, an antineoplastic agent. European Journal of Pharmaceutical Sciences 15 (2002) 163-170
26. Cheng Y.Y., Xu T.W., and Fu R.Q. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen. European Journal of Medicinal Chemistry 40 (2005) 1390-1393
27. Naylor A.M., Goddard I., and Tomalia D.A. Starburst dendrimers 5: molecular shape control. Journal of the American Chemical Society 111 (1989) 2339-2341
28. Bharathi D., Ronald A.H., and Melgardt M.V. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. International Journal of Pharmaceutics 284 (2004) 133-140
29. Cheng Y.Y., and Xu T.W. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. European Journal of Medicinal Chemistry 40 (2005) 1384-1389
30. Cheng Y.Y., Man N., Xu T.W., Fu R.Q., Wang X.Y., Wang X.M., and Wen L.P. Transdermal delivery of non-steroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. Journal of Pharmaceutical Sciences 96 (2007) 565-602
31. Man N., Cheng Y.Y., Xu T.W., Ding Y., Li Z.W., Huang G.Y., Shi Y.Y., and Wen L.P. Dendrimers as potential drug carriers. Part II. Prolonged delivery of Ketoprofen by in vitro and in vivo studies. European Journal of Medicinal Chemistry 41 (2006) 670-674
32. Tong W., Wang L., and D'Souza M.J. Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin. Drug Development and Industrial Pharmacy 29 (2003) 745-756
33. Sætern A.M., Nguyen N.B., Bauer-Brandl A., and Brandl M. Effect of hydroxypropyl-β-cyclodextrin-complexation and pH on solubility of camptothecin. International Journal of Pharmaceutics 284 (2004) 61-68
34. Cortesi R., Esposito E., Maietti A., Menegatti E., and Nastruzzi C. Formulation study for the antitumor drug camptothecin: liposomes, micellar solution, and a microemulusion. International Journal of Pharmaceutics 159 (1997) 95-103
35. Barreiro-Iglesias R., Bromberg L., Temchenko M., Hatton T.A., Concheiro A., and Alvarez-Lorenzo C. Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers. Journal of Controlled Release 97 (2004) 537-549
36. Li Q.Y., Zu Y.G., Shi R.Z., and Yao L.P. Review camptothecin: current perspectives. Current Medicinal Chemistry 13 (2006) 2021-2039
37. Hatefi A., and Amsden B. Camptothecin delivery methods. Pharmaceutical Research 19 (2002) 1389-1399
38. Chen H.T., Neerman M.F., Parrish A.R., and Simanek E.E. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. Journal of the American Chemical Society 126 (2004) 10044-10048
39. Padilla de Jesus O.L., Ihre H., Gagne L., Frechet J.M.J., and Szoka F.C.J. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjugate Chemistry 13 (2002) 453-461
40. Duncan R., and Izzo L. Dendrimer biocompatibility and toxicity. Advanced Drug Delivery Reviews 57 (2005) 2215-2237
41. Morgan M.T., Nakanishi Y., Kroll D.J., Griset A.P., Carnahan M.A., Wathier M., Oberlies N.H., Manikumar G., Wani M.C., and Grinstaff M.W. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Research 66 (2006) 11913-11921